Youfu Luo[Author] - Search Results

Year	Number of Results
2004	1
2007	2
2008	2
2009	6
2010	7
2011	8
2012	7
2013	3
2014	7
2015	5
2016	5
2017	3
2018	6
2019	9
2020	11
2021	16
2022	9
2023	12
2024	9

1

(1R*,5S*)-8-(2-Fluoro-4-nitro-phen-yl)-8-aza-bicyclo-[3.2.1]octan-3-one.

Yang T, Yang J, Li Z, Luo Y. Yang T, et al. Among authors: luo y. Acta Crystallogr Sect E Struct Rep Online. 2011 Dec 1;67(Pt 12):o3297. doi: 10.1107/S1600536811047350. Epub 2011 Nov 12. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 22199799 Free PMC article.

2

Mycobacterium tuberculosis: Pathogenesis and therapeutic targets.

Yang J, Zhang L, Qiao W, Luo Y. Yang J, et al. Among authors: luo y. MedComm (2020). 2023 Sep 4;4(5):e353. doi: 10.1002/mco2.353. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37674971 Free PMC article. Review.

3

5-(4-Chloro-anilinomethyl-ene)-2,2-dimethyl-1,3-dioxane-4,6-dione.

Yang JC, Shi JY, Luo YF, Qiu N, Chen LJ. Yang JC, et al. Acta Crystallogr Sect E Struct Rep Online. 2009 Jun 27;65(Pt 7):o1706. doi: 10.1107/S1600536809023897. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21582958 Free PMC article.

4

5-[(2-Chloro-4-nitro-anilino)methyl-idene]-2,2-dimethyl-1,3-dioxane-4,6-dione.

Lan XQ, Zhang XF, Yang YH, Luo YF. Lan XQ, et al. Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 15;67(Pt 2):o392. doi: 10.1107/S160053681100095X. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21523065 Free PMC article.

5

4-[4-(Piperidin-1-yl)piperidin-1-yl]benzonitrile.

Xu GB, Shi JY, Chen LJ, Luo YF. Xu GB, et al. Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 9;66(Pt 2):o284. doi: 10.1107/S160053680905507X. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21579720 Free PMC article.

6

Repurposed drug candidates for antituberculosis therapy.

An Q, Li C, Chen Y, Deng Y, Yang T, Luo Y. An Q, et al. Among authors: luo y. Eur J Med Chem. 2020 Apr 15;192:112175. doi: 10.1016/j.ejmech.2020.112175. Epub 2020 Feb 25. Eur J Med Chem. 2020. PMID: 32126450 Review.

7

Mitochondrial quality control proteases and their modulation for cancer therapy.

Zhang J, Qiao W, Luo Y. Zhang J, et al. Among authors: luo y. Med Res Rev. 2023 Mar;43(2):399-436. doi: 10.1002/med.21929. Epub 2022 Oct 8. Med Res Rev. 2023. PMID: 36208112 Review.

8

Ribosome-targeting antibacterial agents: Advances, challenges, and opportunities.

Zhang L, He J, Bai L, Ruan S, Yang T, Luo Y. Zhang L, et al. Among authors: luo y. Med Res Rev. 2021 Jul;41(4):1855-1889. doi: 10.1002/med.21780. Epub 2021 Jan 27. Med Res Rev. 2021. PMID: 33501747 Review.

9

Targeting mitochondrial proteases for therapy of acute myeloid leukaemia.

Xiang X, Bao R, Wu Y, Luo Y. Xiang X, et al. Among authors: luo y. Br J Pharmacol. 2022 Jul;179(13):3268-3282. doi: 10.1111/bph.15844. Epub 2022 Apr 15. Br J Pharmacol. 2022. PMID: 35352341 Free article. Review.

10

Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.

Song R, Qiao W, He J, Huang J, Luo Y, Yang T. Song R, et al. Among authors: luo y. J Med Chem. 2021 Mar 25;64(6):2851-2877. doi: 10.1021/acs.jmedchem.0c01640. Epub 2021 Mar 3. J Med Chem. 2021. PMID: 33656892 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year